[Federal Register Volume 59, Number 38 (Friday, February 25, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-4434]


[[Page Unknown]]

[Federal Register: February 25, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

National Heart, Lung, and Blood Institute; Meeting of the 
Clinical Trials Review Committee

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the Clinical Trials Review Committee, National Heart, Lung, 
and Blood Institute, February 28-March 1, 1994, Hyatt Regency Bethesda, 
One Bethesda Metro Center, Bethesda, Maryland 20814.
    The meeting will be open to the public on February 28 from 7 p.m. 
to approximately 7:45 p.m. to discuss administrative details and to 
hear a report concerning the current status of the National Heart, 
Lung, and Blood Institute. Attendance by the public is limited to space 
available.
    In accordance with the provisions set forth in secs. 552b(c)(4) and 
552b(c)(6), title 5, U.S.C., and sec. 10(d) of Public Law 92-463, the 
meeting will be closed to the public on February 28 from approximately 
7:45 p.m. to adjournment on March 1, for the review, discussion and 
evaluation of individual grant applications. These applications and the 
discussions could reveal confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the applications, the disclosure 
of which would constitute a clearly unwarranted invasion of personal 
privacy.
    Ms. Terry Long, Chief, Communications and Public Information 
Branch, National Heart, Lung and Blood Institute, Building 31, room 4A-
21, National Institutes of Health, Bethesda, Maryland 20892, (301) 496-
4236, will provide a summary of the meeting and a roster of the 
Committee members.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretations or other reasonable accommodations, 
should contact the Scientific Review Administrator in advance of the 
meeting.
    Dr. David M. Monsees, Jr., Scientific Review Administrator, 
Clinical Trials Review Committee, Division of Extramural Affairs, 
National Heart, Lung and Blood Institute, Westwood Building, room 550B, 
Bethesda, Maryland 20892, (301) 594-7450, will furnish substantive 
program information.
    This notice is being published less than 15 days prior to the 
meeting due to the difficulty of coordination schedules.

(Catalog of Federal Domestic Assistance Program Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health.)

    Dated: February 22, 1994.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 94-4434 Filed 2-24-94; 8:45 am]
BILLING CODE 4140-01-M